Skip to main content
First new treatment in 30 years for rare disease is effective, tolerable, convenient
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
First new treatment in 30 years for rare disease is effective, tolerable, convenient
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
1
1
Immunoglobulin G (IgG)
0
0.49
Intravenous Immunoglobulin (IVIG)
0
0.48
Rare Diseases
0
0.47
Demyelination
0
0.36
Immunoglobulin A (IgA)
0
0.36
Intravenous
0
0.36
Corticosteroids
0
0.24
Disability
0
0.24
Plasma
0
0.24
Adverse Effects
0
0.12
Board Certification
0
0.12
Fatigue
0
0.12
Neuromuscular Diseases
0
0.12
Neuropathy
0
0.12
Pain
0
0.12
Pathogenesis
0
0.12
Preventive Screening
0
0.12
Quality of Life
0
0.12
Receptors
0
0.12
Weakness
0
0.12
Muscular Atrophy
0
0.06
Myasthenia Gravis
0
0.06
Pain Management
0
0.06
Patient Safety
0
0.06
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Pharmacist
0
0.9
Edit Tags